1. 2735 A review of patient reported toxicity following surgery and adjuvant vaginal vault brachytherapy for endometrial cancer at a UK cancer centre. (September 2015) Authors: Conroy, R.; Whittaker, E.; Routledge, J.; Swindell, R.; Livsey, J.; Davidson, S.; Barraclough, L. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S542 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A national survey of current practices of preparation and management of radical prostate radiotherapy patients during treatment. Issue 2 (May 2017) Authors: Nightingale, H.; Conroy, R.; Elliott, T.; Coyle, C.; Wylie, J.P.; Choudhury, A. Journal: Radiography Issue: Volume 23:Issue 2(2017) Page Start: 87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A Review of Chemotherapy Use in Metastatic Prostate Cancer. Issue 3 (March 2018) Authors: Morrison, S.; Lyons, J.; Conroy, R. Journal: Clinical oncology Issue: Volume 30:Issue 3(2018) Page Start: 194 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Adverse events in healthcare: learning from mistakes. Issue 4 (29th July 2014) Authors: Rafter, N.; Hickey, A.; Condell, S.; Conroy, R.; O'Connor, P.; Vaughan, D.; Williams, D. Journal: QJM Issue: Volume 108:Issue 4(2015) Page Start: 273 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Appropriate patient selection criteria for second line chemotherapy in patients with metastatic bladder cancer. (June 2016) Authors: Raby, S.; Elliot, T.; Choudhury, A.; Conroy, R. Journal: Clinical oncology Issue: Volume 28(2016)Supplement 1 Page Start: S2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Early Real-world Safety Data of Darolutamide in Non-metastatic Castrate-resistant Prostate Cancer. Issue 3 (March 2022) Authors: Elumalai, T.; Syndikus, I.; Sundar, S.; Choudhury, A.; Conroy, R.; Birtle, A. Journal: Clinical oncology Issue: Volume 34:Issue 3(2022) Page Start: e144 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. EP-1586: Docetaxel – Mitigating the high price of success. (April 2018) Authors: Song, Y.P.; Morrison, S.; Lyons, J.; Patel, K.; Coyle, C.; Elliot, P.; Logue, J.; Tran, A.; Wylie, J.; Conroy, R.; Choudhury, A. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S854 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Febrile Neutropenia Rates in Men Treated with Docetaxel Chemotherapy for Metastatic Hormone-sensitive Prostate Cancer. Issue 9 (September 2016) Authors: Mahil, J.; Hughes, C.; Patel, K.; Lyons, J.; Elliott, P.A.; Choudhury, A.; Conroy, R. Journal: Clinical oncology Issue: Volume 28:Issue 9(2016) Page Start: 612 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Impact of COVID-19 on Management of MIBC: a Quantitative and Temporal Analysis. Issue 2 (February 2023) Authors: Kombathula, S.H.; Anjanappa, M.; Song, Y.P.; Conroy, R.; Wylie, J.; Choudhury, A. Journal: Clinical oncology Issue: Volume 35:Issue 2(2023) Page Start: e240 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. PO-1338 Does frailty influence treatment intent in men with non-metastatic prostate cancer?. (August 2021) Authors: Connors, K.; Vickers, A.; Conroy, R.; Coyle, C.; Hudson, A.; Logue, J.; Serra, M.; Tran, A.; Mistry, H.; Wylie, J.; Choudhury, A.; Song, Y.P. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S1099 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗